Reata Pharmaceuticals (RETA) Stock Forecast for 2024–2028. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for RETA stock
Reata Pharmaceuticals, Inc. Analysis
RETA Stock News


Popular stocks:
Suncor Energy
Tilray
QUALCOMM
Square

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Kandi Technologies Group
GitLab
Southern
Array Technologies
Lyft
Dominion Energy
Himax Technologies
Qualtrics International
Hanover Bancorp
Moderna


Financial News

Popular Stocks Analysis

Helpful Highlights
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. RETA

Reata Pharmaceuticals (RETA) Stock Forecast for 2024–2028. Sell or Buy?

Updated: May 4, 2024 (00:44)

Sector: Healthcare

The share price of Reata Pharmaceuticals, Inc. (RETA) now

This company is DELISTED
Latest session on the 26th of September for
Reata Pharmaceuticals, Inc. is negative
Trading Volume: 0
Open: 172.36 /  High: 172.36 /  Low: 172.36
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Reata Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Reata Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Reata Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Reata Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Reata Pharmaceuticals share be worth in 2024 - 2028?

When should I take profit in Reata Pharmaceuticals stock? When should I record a loss on Reata Pharmaceuticals stock? What are analysts' forecasts for Reata Pharmaceuticals stock? What is the future of Reata Pharmaceuticals stock? We forecast Reata Pharmaceuticals stock performance using neural networks based on historical data on Reata Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Reata Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Reata Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Reata Pharmaceuticals stock

The chart below shows the historical price of Reata Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Reata Pharmaceuticals stock price can be found in the table below.

No data

Long-term forecasts by years.

Reata Pharmaceuticals, Inc., a clinical biopharmaceutical company, is developing new therapies for patients with serious or life-threatening illnesses by targeting molecular pathways that regulate cellular metabolism and inflammation.

Reata Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
May 05 175.14 170.59 177.86 4.26
May 06 177.59 170.76 182.30 6.76
May 07 179.55 173.08 182.51 5.45
May 08 173.26 171.53 177.16 3.28
May 09 172.74 170.76 178.27 4.40
May 10 177.06 174.23 183.52 5.33
May 11 181.22 176.42 184.21 4.42
May 12 177.69 171.03 184.17 7.69
May 13 170.58 166.66 172.63 3.58
May 14 166.66 164.41 173.32 5.42
May 15 164.33 159.07 166.87 4.91
May 16 171.88 165.18 176.52 6.87
May 17 168.53 164.15 173.34 5.60
May 18 166.17 160.27 168.50 5.13
May 19 170.83 165.53 174.24 5.26
May 20 176.72 172.21 183.61 6.62
May 21 181.76 176.48 184.94 4.79
May 22 183.03 181.20 189.71 4.70
May 23 177.99 170.96 183.78 7.50
May 24 179.15 172.52 181.21 5.04
May 25 177.81 171.67 182.70 6.42
May 26 170.07 167.69 175.01 4.36
May 27 167.01 162.59 171.60 5.55
May 28 163.17 156.97 164.88 5.04
May 29 162.84 158.94 167.73 5.53
May 30 163.58 157.03 169.96 8.23
May 31 158.42 153.36 162.78 6.15
Jun 01 158.66 156.12 162.63 4.17
Jun 02 155.33 150.13 158.28 5.43
Jun 03 154.40 150.92 158.80 5.22

Reata Pharmaceuticals Daily Price Targets


Reata Pharmaceuticals Stock Forecast 05-05-2024.

Forecast target price for 05-05-2024: $175.14.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.086%.
Pessimistic target level: 170.59
Optimistic target level: 177.86

Reata Pharmaceuticals Stock Forecast 05-06-2024.

Forecast target price for 05-06-2024: $177.59.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 6.332%.
Pessimistic target level: 170.76
Optimistic target level: 182.30

Reata Pharmaceuticals Stock Forecast 05-07-2024.

Forecast target price for 05-07-2024: $179.55.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 5.165%.
Pessimistic target level: 173.08
Optimistic target level: 182.51

Reata Pharmaceuticals Stock Forecast 05-08-2024.

Forecast target price for 05-08-2024: $173.26.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 3.178%.
Pessimistic target level: 171.53
Optimistic target level: 177.16

Reata Pharmaceuticals Stock Forecast 05-09-2024.

Forecast target price for 05-09-2024: $172.74.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.215%.
Pessimistic target level: 170.76
Optimistic target level: 178.27

Reata Pharmaceuticals Stock Forecast 05-10-2024.

Forecast target price for 05-10-2024: $177.06.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 5.065%.
Pessimistic target level: 174.23
Optimistic target level: 183.52

RETA (RETA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jun. 158.57 136.69 168.40 18.83
Jul. 156.67 143.51 175.47 18.21
Aug. 164.50 145.75 180.95 19.45
Sep. 169.11 159.64 192.45 17.05
Oct. 175.87 150.90 189.94 20.56
Nov. 188.18 161.84 214.15 24.43
Dec. 172.38 163.07 179.62 9.21
Full forecast for 2024

Reata Pharmaceuticals forecast for this year


Reata Pharmaceuticals Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $158.571. Pessimistic: $136.69. Optimistic: $168.40


Reata Pharmaceuticals Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $156.668. Pessimistic: $143.51. Optimistic: $175.47


Reata Pharmaceuticals Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $164.502. Pessimistic: $145.75. Optimistic: $180.95


Reata Pharmaceuticals Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $169.108. Pessimistic: $159.64. Optimistic: $192.45


Reata Pharmaceuticals Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $175.872. Pessimistic: $150.90. Optimistic: $189.94


Reata Pharmaceuticals Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $188.183. Pessimistic: $161.84. Optimistic: $214.15


Reata Pharmaceuticals Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $172.376. Pessimistic: $163.07. Optimistic: $179.62



Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 167.89 142.04 175.28 18.97
Feb 180.32 164.09 197.63 16.97
Mar 170.94 161.71 184.96 12.57
Apr 146.67 137.28 157.82 13.01
May 139.63 134.04 145.77 8.05
Jun 154.15 140.89 172.34 18.25
Jul 157.23 147.17 177.99 17.31
Aug 177.04 167.48 187.31 10.59
Sep 174.92 148.68 188.91 21.30
Oct 203.61 183.65 212.97 13.77
Nov 188.13 158.41 217.10 27.04
Dec 218.23 195.10 228.27 14.53
Full forecast for 2025

Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 180.26 151.78 187.47 19.04
Feb 149.62 134.36 160.99 16.54
Mar 147.52 131.29 164.04 19.96
Apr 128.64 110.37 146.65 24.74
May 131.21 117.04 149.32 21.62
Jun 132.00 119.59 140.71 15.01
Jul 141.77 130.71 162.18 19.41
Aug 164.73 147.93 178.24 17.01
Sep 151.55 144.89 175.80 17.59
Oct 165.50 154.91 179.07 13.49
Nov 156.56 142.16 174.72 18.64
Dec 151.55 133.97 159.13 15.81
Full forecast for 2026

Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 143.97 124.68 157.51 20.84
Feb 139.37 129.33 149.40 13.43
Mar 147.17 134.81 163.36 17.48
Apr 149.82 142.03 170.49 16.70
May 177.39 154.33 186.61 17.30
Jun 162.49 152.09 187.83 19.03
Jul 190.11 176.80 206.84 14.52
Aug 196.57 186.74 206.01 9.35
Sep 186.35 177.41 206.85 14.23
Oct 172.56 154.61 200.17 22.76
Nov 183.26 159.80 210.75 24.17
Dec 176.66 161.47 199.63 19.11
Full forecast for 2027

Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 171.72 145.61 191.63 24.01
Feb 181.67 169.68 207.47 18.21
Mar 211.83 183.45 241.07 23.90
Apr 241.49 228.45 255.98 10.75
May 279.16 255.15 295.35 13.61
Jun 319.92 278.97 367.91 24.17
Jul 290.49 255.05 334.64 23.78
Aug 264.92 226.77 293.01 22.60
Sep 277.64 245.99 300.96 18.27
Oct 282.08 245.41 304.65 19.44
Nov 277.00 263.71 295.29 10.69
Dec 227.14 197.16 247.59 20.37
Full forecast for 2028

Reata Pharmaceuticals information and performance

Reata Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Reata Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RETA shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Reata Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector

Immuron Limited (IMRN)
BioDelivery Sciences International, Inc. (BDSI)
Danaher Corp. (DHR)
Abiomed, Inc. (ABMD)
Oramed Pharmaceuticals Inc. (ORMP)
Aridis Pharmaceuticals, Inc. (ARDS)
bluebird bio, Inc. (BLUE)
Enveric Biosciences, Inc. (ENVB)
Antares Pharma, Inc. (ATRS)
Allogene Therapeutics, Inc. (ALLO)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website